Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma
Clinical trial NCT03261349 · UNKNOWN
Trial details
- NCT number
- NCT03261349
- Sponsor
- National Taiwan University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2020-12-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.